Development and in-vitro evaluation of an optimized carvedilol transdermal therapeutic system using experimental design approach

Lyons, 2007, Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process, Int J Pharm, 329, 62, 10.1016/j.ijpharm.2006.08.028 Wen, 2004, Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin, J Pharm Biomed Anal, 34, 517, 10.1016/S0731-7085(03)00576-4 Wen, 2009, Carvedilol ameliorates the decreases in connexin 43 and ventricular fibrillation threshold in rats with myocardial infarction, Tohoku J Exp Med, 218, 121, 10.1620/tjem.218.121 Ubaidulla, 2007, Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics, AAPS PharmSciTech, 8, 2, 10.1208/pt0801002 Feldstein, 1996, Hydrophilic polymeric matrices for enhanced transdermal drug delivery, Int J Pharm, 131, 229, 10.1016/0378-5173(95)04351-9 Wei, 2005, Preparation and evaluation of SEDDS and SMEDDS containing carvedilol, Drug Dev Ind Pharm, 31, 785, 10.1080/03639040500216428 Stamatialis, 2002, Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions, J Control Release, 81, 335, 10.1016/S0168-3659(02)00076-7 Korsmeyer, 1983, Mechanisms of solute release from porous hydrophilic polymers, Int J Pharm, 15, 25, 10.1016/0378-5173(83)90064-9 Hai, 2008, Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine, Int J Pharm, 357, 55, 10.1016/j.ijpharm.2008.01.024 Siepmann, 2001, Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC), Adv Drug Deliv Rev, 48, 139, 10.1016/S0169-409X(01)00112-0 Schwarb, 1999, Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin, Pharm Res, 16, 909, 10.1023/A:1018890422825 Padula, 2007, Single-layer transdermal film containing lidocaine: modulation of drug release, Eur J Pharm Biopharm, 66, 422, 10.1016/j.ejpb.2006.11.014 Guyot, 2000, Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol, Int J Pharm, 204, 171, 10.1016/S0378-5173(00)00494-4 Yamane, 1995, Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action, J Pharm Pharmacol, 47, 978, 10.1111/j.2042-7158.1995.tb03282.x Hadgraft, 1999, Passive enhancement strategies in topical and transdermal drug delivery, Int J Pharm, 184, 1, 10.1016/S0378-5173(99)00095-2 Thomas, 2003, Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action, Eur J Pharm Sci, 18, 71, 10.1016/S0928-0987(02)00242-7 Melero, 2008, Nortriptyline hydrochloride skin absorption: development of a transdermal patch, Eur J Pharm Biopharm, 69, 588, 10.1016/j.ejpb.2007.11.012 Levang, 1999, Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin, Int J Pharm, 181, 255, 10.1016/S0378-5173(99)00055-1 Williams, 2004, Penetration enhancers, Adv Drug Deliv Rev, 56, 603, 10.1016/j.addr.2003.10.025 Pershing, 1990, Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo, Pharm Res, 7, 170, 10.1023/A:1015832903398